Protein-protein interactions for pharmacological profiling
AU2012216338A1
Harnessing network biology to improve drug discovery
AU2012208983A1
Kinase inhibitors for the treatment of diabetes and obesity
AU2011256908A1
Methods for identifying new drug leads and new therapeutic uses for known drugs
AU2011254093A1
Pharmacological profiling of drugs with cell-based assays
US2010081632A1
High-content and high throughput assays for identification of lipid-regulating pathways, and novel therapeutic agents for lipid disorders
US2007212677A1
Identifying off-target effects and hidden phenotypes of drugs in human cells
US2006160109A1
Harnessing network biology to improve drug discovery
US2006094682A1
Kinase inhibitors for the treatment of diabetes and obesity
EP1797427A2
Methods for identifying new drug leads and new therapeutic uses for known drugs
US2006094059A1
Methods for identifying new drug leads and new therapeutic uses for known drugs
US2006040338A1
Pharmacological profiling of drugs with cell-based assays
AU2005203580A1
Protein Fragment Complementation Assays to Detect Biomolecular Interactions
US2006009506A1
Drugs for the treatment of neoplastic disorders
US2005221280A1
Protein-protein interactions for pharmacological profiling
US7488583B2
Fragment complementation assays for G-protein-coupled receptors and their signaling pathways
US7306914B2
Protein fragment complementation assays in whole animals applications to drug efficacy, ADME, cancer biology, immunology, infectious disease and gene therapy
WO2005001115A2
Monitoring gene silencing and annotating gene function in living cells
US2004161787A1
Protein fragment complementation assays for high-throughput and high-content screening
US7855167B2
In vivo screening of protein-protein interactions with protein-fragment complementation assays
